Literature DB >> 16858282

Clinical utility of histological features of polyomavirus allograft nephropathy.

Lillian W Gaber1, M Francesca Egidi, Robert J Stratta, Agnes Lo, Linda W Moore, A Osama Gaber.   

Abstract

BACKGROUND: The purpose of this study was to determine if histological features of polyomavirus allograft nephropathy (PVAN) are associated with the clinical presentation and outcomes of PVAN.
METHODS: We examined the histological features of initial and follow-up biopsies of 20 kidney and kidney-pancreas transplant recipients with PVAN during a time prior to routine surveillance. The subjects' demographics, clinical characteristics, and outcomes were compared based upon classification of histological features of PVAN on initial biopsy.
RESULTS: Diabetes mellitus (45%) and a history of tacrolimus-induced nephrotoxicity (35%) appeared to be prevalent in subjects with PVAN. Although histological severity of PVAN did not predict or correlate with the clinical course of PVAN, subjects with pattern C on initial PVAN biopsy presented later posttransplant, had higher serum creatinine level at presentation, and had significant allograft deterioration at follow-up than subjects with either pattern A or B on initial biopsy. Resolution of PVAN was noted in 60% of follow-up biopsies and occurred more frequently in subjects with pattern B on initial biopsy. Most subjects developed chronic allograft nephropathy after PVAN and viral clearance did not abrogate the progression to chronic allograft nephropathy.
CONCLUSIONS: These data indicate that histologic patterns of PVAN may have clinical correlation to disease presentation and prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858282     DOI: 10.1097/01.tp.0000226176.87700.a4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.

Authors:  Darshana Dadhania; Catherine Snopkowski; Ruchuang Ding; Thangamani Muthukumar; Jun Lee; Heejung Bang; Vijay K Sharma; Surya Seshan; Phyllis August; Sandip Kapur; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

2.  The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.

Authors:  K Masutani; R Shapiro; A Basu; H Tan; M Wijkstrom; P Randhawa
Journal:  Am J Transplant       Date:  2012-03-05       Impact factor: 8.086

3.  Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.

Authors:  Thurid Ahlenstiel-Grunow; Lars Pape
Journal:  Pediatr Nephrol       Date:  2019-12-19       Impact factor: 3.714

4.  Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus -Associated Nephropathy after Renal Transplantation.

Authors:  Gang Huang; Lin-wei Wu; Shi-Cong Yang; Ji-guang Fei; Su-xiong Deng; Jun Li; Guo-dong Chen; Qian Fu; Rong-hai Deng; Jiang Qiu; Chang-xi Wang; Li-zhong Chen
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

Review 5.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.